Showing results (41-50 of 165) with videos related to
Sort By:
Pageof 17
International Journal of Oncology|October 9, 2002
Isolated trisomy of chromosomes 8, 11, 13 and 21 is an adverse prognostic factor in adults with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B 8461Sherif S Farag, Kellie J Archer, Krzysztof Mrózek, et al.Molecular Cancer Therapeutics|June 6, 2019
Prognostic and Biologic Relevance of Clinically Applicable Long Noncoding RNA Profiling in Older Patients with Cytogenetically Normal Acute Myeloid LeukemiaDimitrios Papaioannou, Deedra Nicolet, Hatice G Ozer, et al.International Journal of Oncology|June 18, 2004
Prognostic significance of additional cytogenetic abnormalities in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-alpha: a Cancer and Leukemia Group B studySherif S Farag, Amy S Ruppert, Krzysztof Mrózek, et al.Blood|April 5, 2008
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group studyMichael J Borowitz, Meenakshi Devidas, Stephen P Hunger, et al.Cancer Research|October 28, 2016
Mutational Landscape and Gene Expression Patterns in Adult Acute Myeloid Leukemias with Monosomy 7 as a Sole AbnormalityAnn-Kathrin Eisfeld, Jessica Kohlschmidt, Krzysztof Mrózek, et al.Pediatric Blood & Cancer|March 2, 2011
Augmented therapy improves outcome for pediatric high risk acute lymphocytic leukemia: results of Children's Oncology Group trial P9906W Paul Bowman, Eric L Larsen, Meenakshi Devidas, et al.Journal of Hematology & Oncology|July 7, 2021
Precision oncology in AML: validation of the prognostic value of the knowledge bank approach and suggestions for improvementMarius Bill, Krzysztof Mrózek, Brian Giacopelli, et al.Pediatric Blood & Cancer|June 1, 2023
Minimal residual disease predicts outcomes in KMT2A-rearranged but not KMT2A-germline infant acute lymphoblastic leukemia: Report from Children's Oncology Group study AALL0631Kelly E Faulk, John A Kairalla, ZoAnn E Dreyer, et al.Blood|March 8, 2007
Long-term disease-free survivors with cytogenetically normal acute myeloid leukemia and MLL partial tandem duplication: a Cancer and Leukemia Group B studySusan P Whitman, Amy S Ruppert, Guido Marcucci, et al.Leukemia|August 30, 2019
Clinical and molecular characterization of patients with acute myeloid leukemia and sole trisomies of chromosomes 4, 8, 11, 13 or 21Bhavana Bhatnagar, Ann-Kathrin Eisfeld, Jessica Kohlschmidt, et al.Pageof 17